These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis? Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681 [TBL] [Abstract][Full Text] [Related]
9. Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Ingall TJ; O'Fallon WM; Asplund K; Goldfrank LR; Hertzberg VS; Louis TA; Christianson TJ Stroke; 2004 Oct; 35(10):2418-24. PubMed ID: 15345796 [TBL] [Abstract][Full Text] [Related]
10. Protocol violations in community-based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage. Lopez-Yunez AM; Bruno A; Williams LS; Yilmaz E; Zurrú C; Biller J Stroke; 2001 Jan; 32(1):12-6. PubMed ID: 11136907 [TBL] [Abstract][Full Text] [Related]
11. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience. Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460 [TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Graham GD Stroke; 2003 Dec; 34(12):2847-50. PubMed ID: 14605319 [TBL] [Abstract][Full Text] [Related]
13. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital]. Takahashi K; Iijima K; Oguro H; Bokura H; Nagai A; Yamaguchi S; Kobayashi S No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212 [TBL] [Abstract][Full Text] [Related]
14. Intraarterial thrombolytic therapy within 3 hours of the onset of stroke. Bourekas EC; Slivka AP; Shah R; Sunshine J; Suarez JI Neurosurgery; 2004 Jan; 54(1):39-44; discussion 44-6. PubMed ID: 14683539 [TBL] [Abstract][Full Text] [Related]
15. Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator. Cocho D; Borrell M; Martí-Fàbregas J; Montaner J; Castellanos M; Bravo Y; Molina-Porcel L; Belvís R; Díaz-Manera JA; Martínez-Domeño A; Martínez-Lage M; Millán M; Fontcuberta J; Martí-Vilalta JL Stroke; 2006 Apr; 37(4):996-9. PubMed ID: 16497981 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness. Buchan AM; Barber PA; Newcommon N; Karbalai HG; Demchuk AM; Hoyte KM; Klein GM; Feasby TE Neurology; 2000 Feb; 54(3):679-84. PubMed ID: 10680803 [TBL] [Abstract][Full Text] [Related]
17. Very mild stroke patients benefit from intravenous tissue plasminogen activator without increase of intracranial hemorrhage. Hassan AE; Hassanzadeh B; Tohidi V; Kirmani JF South Med J; 2010 May; 103(5):398-402. PubMed ID: 20375952 [TBL] [Abstract][Full Text] [Related]
18. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials. Majidi S; Leon Guerrero CR; Burger KM; Sigounas D; Olan WJ; Qureshi AI J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113 [TBL] [Abstract][Full Text] [Related]
19. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator. Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999 [TBL] [Abstract][Full Text] [Related]
20. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]